The Massachusetts Attorney General’s lawsuit against UnitedHealthcare alleges a decade-long scheme to inflate diagnoses for dual-eligible enrollees, netting at least $100 million in improper payments. While the complaint focuses on one state executive’s resignation amid profit pressure, it underplays how these tactics mirror documented Medicare Advantage upcoding patterns that have drawn federal scrutiny for years. Dual eligibles—low-income seniors dually enrolled in Medicare and Medicaid—represent a uniquely vulnerable population where upcoding directly erodes access to coordinated care. Analyses from the HHS Office of Inspector General (OIG), drawing on observational audits of millions of claims rather than RCTs, have repeatedly flagged risk-adjustment manipulation across insurers, with UnitedHealth frequently cited in settlement data exceeding $1 billion. A 2023 Kaiser Family Foundation review of CMS data further shows dual-eligible plans concentrate in high-revenue markets, creating incentives that prioritize coding intensity over clinical outcomes. The STAT coverage misses the downstream effect on senior wellness: inflated risk scores can shift resources toward administrative coding teams rather than preventive services, potentially worsening chronic disease management in populations already facing fragmented care. Conflicts of interest abound, as UnitedHealth’s Optum subsidiary both provides analytics tools used for coding and owns provider networks that deliver the care being coded. This case signals broader exposure for state Medicaid budgets already strained by post-pandemic enrollment shifts, with implications for care access that extend far beyond Massachusetts.